Endologix (ELGX) Misses Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Piper Jaffray Cuts Price Target on Endologix (ELGX) to $20 Following 2Q15
August 4, 2015 8:29 AM EDTPiper Jaffray maintained an Overweight rating on Endologix (NASDAQ: ELGX), and cut the price target to $20.00 (from $21.00), following 2Q15 results. Endologix reported revenues of $39.5M, just ahead of consensus $39.4M.
Analyst Brooks West commented, "Endologix reported 2Q15 revenues of $39.5M (+8%cc) just ahead... More
Canaccord Genuity Downgrades Endologix (ELGX) to Hold
August 4, 2015 7:03 AM EDTCanaccord Genuity downgraded Endologix (NASDAQ: ELGX) from Buy to Hold with a price target of $14.00 (from $18.50).
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $14.06 yesterday.
... More
